Case Study: ACUTA reduces patient wait times by streamlining regulatory submissions with Microsoft Azure

Reduce patient wait time for drugs and devices with streamlined submissions process

ACUTA, a U.S. regulatory information management company founded in 2012, created ARIM to tackle the slow, costly paperwork and fragmented systems that delay drug and device approvals. Pharmaceutical firms and small biotech startups face information silos, repeated multi-country submissions, and heavy IT/compliance overhead that prolong approval timelines and keep treatments from patients.

ARIM is a cloud-based platform hosted on Microsoft Azure with modules for correspondence and commitments, submission planning, publishing/validation, e-submission viewing, and global registration and tracking. By centralizing regulatory data, supporting eCTD and other submission formats, and delivering a managed, always-updated service, ARIM shortens internal review cycles, reduces IT burdens, and helps life sciences organizations accelerate time to market while maintaining secure, compliant operations.

ACUTA

Shylendra Kumar

CEO